FDA Requires New Opioid Label Warnings Over Risks Of Suddenly Stopping Treatment
The FDA is requiring opioids to carry new label warning about the risks of sudden discontinuation, which can lead to withdrawal symptoms, pain and suicide.…
«
»
The FDA is requiring opioids to carry new label warning about the risks of sudden discontinuation, which can lead to withdrawal symptoms, pain and suicide.…
An ISMP report questions the FDA conclusions that there are no new safety signals with the Parkinson’s disease psychosis drug, Nuplazid.…
A teenager prescribed Lamictal off-label suffered Stevens-Johnson Syndrome and was hospitalized for two weeks due to the drug’s side effects.…
A new CDC report indicates a number of serious events have been linked to the use of Shingrix, but indicates the vaccine is safe overall.…
The FDA has issued two new draft guidance for industry on how to best manage programs designed to mitigate adverse events from high risks drugs.…
A case report warns that Bactrim and Septra could cause a potentially deadly skin rash that first manifests as vaginal lesions.…
Participants at a recent FDA hearing said there is little data on whether smoking cessation drugs like Chantix and Zyban would be useful in treating teen electronic cigarette addictions.…
The FDA is withdrawing a proposed rule that would have required generic drug manufacturers to update drug labels when dangerous side effects were discovered.…
The FDA is urging consumers not to use Rhino over-the-counter male enhancement pills following reports of hospitalizations and tests indicating they illegally contain the active ingredient for Viagra.…
The FDA has issued a new Gilenya warning, indicating that halting treatment of the MS drug can result in worsening symptoms and disability.…